RxDoctor Payments Data

Lan Quach

Physician Assistant · San Diego, CANPI 1730462904

Payments from drug & device makers

$16,297in general payments, 2019–2025

Across 415 payments — averaging $39.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$2K
  • Otsuka America Pharmaceutical, Inc.$2K
  • AbbVie$2K
  • Axsome Therapeutics, Inc.$2K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • Lundbeck LLC$1K
  • plus $5K from 14 others

What the payments were for

  • Consulting fees$1151%
  • Food & beverage$16,12099%
  • Education$630%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,297 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl96$119,853
Austedo XrDeutetrabenazine14$111,362
RexultiBrexpiprazole11$18,096
Lurasidone Hcl11$13,057
Trazodone Hcl43$726
Duloxetine Hcl43$592
Bupropion XlBupropion Hcl43$391
Quetiapine Fumarate36$380
Gabapentin35$331
Desvenlafaxine Succinate ErDesvenlafaxine Succinate14$271
Clonazepam29$172
Aripiprazole14$134
Lamotrigine16$122
Fluoxetine Hcl13$118
Mirtazapine25$107

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$835$119,85396 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$514$111,36214 claims
Otsuka America Pharmaceutical, Inc.Rexulti$2,003$18,09611 claims
Almatica Pharma LLCSertraline Hcl$287$9121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →